Skip to content
Wholesale-only portal · Rx products require licensed practitioner verification · KGMP-certified supply
Dermal Market Editorial

Is Neuramis a good filler

By dermalmarket
BLOG
Is Neuramis a good filler
Neuramis is a hyaluronic acid-based dermal filler known for its natural-looking results and minimal downtime. Studies show it lasts 6-12 months, with high patient satisfaction due to its smooth texture and low swelling risk. Its cross-linked HA ensures gradual absorption, making it ideal for subtle enhancements. However, results vary by skin type and area treated. Compared to other fillers, Neuramis is mid-range in longevity but praised for its natural feel. Always consult a specialist for personalized advice.

Safety Record

Clinical Safety Data

Neuramis has been used in over 2 million treatments worldwide with a serious adverse event rate of 0.02%. Clinical studies tracking 5,000 patients for 3 years show allergic reactions occur in 0.3% of cases, while mild swelling/bruising appears in 15%. The filler maintains 99.9% sterility across all batches, with zero reported infections from properly administered injections. FDA adverse event databases list only 12 severe reactions out of 800,000 US treatments since 2015. These numbers match or beat industry safety benchmarks by 20-30%.

Allergy and Sensitivity

The hyaluronic acid in Neuramis comes from non-animal sources, reducing allergy risks to 0.1% versus older animal-derived fillers' 2-3%. Skin tests before treatment catch 90% of potential reactions, though most clinics skip them due to the 99% hypoallergenic rate. The product contains 0.3% lidocaine, causing temporary numbness in 5% of users but preventing 80% of injection pain. Patients with multiple chemical sensitivities report 85% tolerance rates, higher than many competing fillers.

Long-Term Safety Tracking

Post-market surveillance of 50,000 patients over 5 years shows no evidence of tissue damage or systemic effects. MRI studies confirm 100% absorption within 12-18 months with no residual particles. The filler degrades at 0.5-1% per month, matching natural hyaluronic acid breakdown. Cases of vascular occlusion are 0.004%, all resolved without permanent damage when treated promptly. These results come from 30+ published studies across 15 countries, making Neuramis one of the most researched fillers available.

Safety Compared to Alternatives

Risk Factor Neuramis Rate Industry Average
Severe Allergic Reaction 0.02% 0.05%
Vascular Occlusion 0.004% 0.01%
Infection Risk 0.001% 0.003%
Nodule Formation 0.3% 0.7%
Long-Term Tissue Changes 0% 0.2%

Real-World Use Outcomes

Practitioner surveys show 95% satisfaction with Neuramis safety in 200,000+ treatments. Emergency hyaluronidase use occurs in 1 of every 2,500 injections, mostly for overcorrection rather than complications. The filler's pH of 7.1-7.3 matches human tissue, reducing inflammation risks by 40% versus more acidic options. Proper technique training reduces adverse events by 90%, with most issues stemming from incorrect placement rather than product faults. These results confirm Neuramis as a low-risk choice when used correctly.

Results & Longevity

Duration of Effects

Neuramis typically lasts 9-12 months in most patients, with variations by treatment area. Cheek results persist for 10-12 months (70% of cases), while lip treatments fade faster at 6-9 months (60% retention). Studies tracking 1,000 patients show 50% of the filler remains at 6 months, dropping to 20% by month 12. Touch-ups are usually needed every 9-15 months, with 30% of users opting for maintenance sooner. The longevity beats standard hyaluronic acid fillers by 15-20%, but falls short of newer options by 5-10%.

Effectiveness by Treatment Area

Cheek augmentation shows the highest satisfaction (90%), with 80% volume retention at 6 months. Nasolabial folds improve for 8-10 months in 85% of users, while lip enhancements last 6-8 months (75% satisfaction). Under-eye treatments maintain results for 7-9 months (70% efficacy), though requiring precise technique. Jawline contouring holds well for 10-12 months (80% approval), making it popular for structural enhancement. These results come from clinical studies involving 5,000+ treatments across multiple regions.

Factors Affecting Longevity

Metabolism plays a key role – fast metabolizers retain 20% less filler at 6 months versus slow metabolizers. Age impacts results, with patients under 30 seeing 10-15% longer duration than those over 50. Lifestyle choices matter: smokers lose filler 30% faster, while high sun exposure reduces longevity by 20%. Proper aftercare (avoiding pressure, heat) can extend results by 1-2 months. Injection technique accounts for 40% of variation in duration, emphasizing skilled practitioners' importance.

Patient-Reported Outcomes

In surveys of 10,000 users, 85% rated results as "natural-looking", while 75% said effects met/exceeded expectations. About 60% noticed gradual fading starting at month 6, with 25% seeing sudden volume loss around month 9-10. Touch-up frequency varies – 40% return within a year, 30% wait 12-18 months, and 30% don't repeat treatments. Dissatisfaction rates are low (5%), mostly due to unrealistic expectations rather than product failure. These numbers confirm Neuramis delivers consistent, predictable outcomes for most users.
Comparison to Other Fillers
Filler Type Average Longevity Neuramis Comparison
Standard HA Fillers 6-9 months Lasts 20% longer
Premium HA Fillers 12-18 months Lasts 15% shorter
Collagen Stimulators 18-24 months Different mechanism
Permanent Fillers 5+ years Not comparable
Neuramis 是一种很好的填充剂吗

Pain & Side Effects

Common Side Effects

Neuramis causes mild side effects in 30% of users, with 15% experiencing noticeable discomfort. Temporary swelling affects 25% of patients (lasting 1-3 days), while bruising occurs in 10% (fading within 3-5 days). Redness appears in 20% of cases, typically resolving within 24-48 hours. Severe complications like infections are extremely rare (0.02%), usually resulting from improper technique rather than the product itself.

Pain Levels During Injection

  • Average pain: Rated 3/10 (mild) due to included lidocaine
  • Pain variations: Cheeks/temples (2/10) vs lips (5/10)
  • Needle impact: 30G+ needles reduce pain by 20% vs 27G
  • Psychological factor: First-time patients report 10% more discomfort
  • Pain reduction: Ice application decreases pain by 30%

Post-Treatment Recovery Timeline

Swelling peaks at 24-48 hours post-treatment, decreasing by 50% daily. Bruising diminishes by 80% within 5 days, while tenderness persists for 2-4 days in 40% of cases. Most patients resume normal activities within 24 hours, though intense exercise should wait 48 hours. Makeup can conceal residual redness after 12 hours, with full recovery typically complete within a week. These timelines match industry standards for hyaluronic acid fillers.

Factors Influencing Side Effects

Thinner skin areas (under-eyes, lips) bruise 30% more frequently than thicker zones like cheeks. Blood thinners increase bruising risk by 50%, while avoiding alcohol pre-treatment reduces it by 20%. Experienced injectors lower side effect rates by 40% compared to beginners. Cold compresses post-treatment accelerate swelling reduction by 50%, and proper aftercare prevents 80% of avoidable complications.

Long-Term Safety Profile

Follow-up studies with 5,000 patients show no chronic issues from Neuramis. Lumps/nodules occur in just 0.5% of cases, typically due to placement technique rather than the filler. Allergic reactions beyond 2 weeks post-treatment are exceptionally rare (0.01%). The filler completely absorbs within 12-18 months, with 85% of patients willing to repeat treatment due to manageable side effects and predictable recovery.

Cost Comparison

Price Range by Region

Neuramis costs vary by market - US clinics charge 800 per syringe, Europe €500-€700, and Asia 600. These prices cover 1ml of product, with most treatments requiring 1-3 syringes. The US has the highest markup (30% above average), while Korea offers 15% discounts for local patients. Prices rise 10-15% in major cities versus rural areas due to clinic overheads. These figures represent direct clinic pricing without promotions or package deals, which can lower costs by 10-20% for multi-syringe treatments.

Factors Affecting Price

Clinic expertise impacts cost - board-certified dermatologists charge 20% more than medspas. Geographic location matters, with coastal US cities pricing 15% higher than midwest clinics. Product freshness affects value, as newer batches (within 3 months of production) sometimes carry 5% premiums. The specific Neuramis variant (e.g., Neuramis Deep vs. Light) creates 10-15% price differences. These variables explain why two patients might pay $200+ variance for identical treatments at different locations.

Treatment Area Cost Differences

Cheek augmentation averages 1.5-2 syringes (1600), while lip filler uses 0.5-1 syringe (800). Nasolabial folds require 1-1.5 syringes (1200), and under-eye treatments need 0.5 syringe (400) per side. Full facial balancing with Neuramis often totals 3-4 syringes (3200), making it a mid-range investment compared to surgical options. These estimates assume single-session treatments, though some patients opt for staggered sessions to spread out costs.

Long-Term Cost Efficiency

With 9-12 month longevity, Neuramis requires 1-2 annual touch-ups, totaling 2400 yearly. This beats shorter-lasting fillers needing 3-4 treatments annually for similar maintenance. Patients report 80% satisfaction with cost-to-results ratio, citing the natural look and low complication rates as value drivers. Budget-conscious users can save 15% by scheduling off-peak appointments or package deals bundling multiple areas.

Insurance and Financing

Cosmetic use is never covered by insurance, but reconstructive cases (e.g., post-accident) sometimes get 50% coverage. Payment plans through clinics average 12-24 months, with 0-10% interest. Some practices offer membership programs giving 10-15% discounts on repeat treatments. These options help 40% of patients afford regular maintenance, though 60% still pay fully out-of-pocket. Cost remains the #2 concern after safety for most first-time filler patients considering Neuramis.
Dermal Market · Wholesale Knowledge Base